Safety and efficacy of the new CryoPop® cryotherapy device for cervical dysplasia in low- and middle-income countries: study protocol for a multicenter open-label non-inferiority clinical trial with historical controls
Authors:
- Jean AndersonJAJean Anderson
- Enriquito LuELEnriquito Lu
- Edward KenyiEKEdward Kenyi
- Margaret MensaMMMargaret Mensa
- Katrina ThalerKTKatrina Thaler
- Ramalingappa AntartaniRARamalingappa Antartani
- Kasturi DonimathKDKasturi Donimath
- Basavaraj PatilBPBasavaraj Patil
- Santosh ChikaraddiSCSantosh Chikaraddi
- Shailaja BidriSBShailaja Bidri
- Aruna BiradarABAruna Biradar
Open Access
- 13 December 2021
- journal article
- research article
- Published by Springer Nature in Trials
- Vol. 22 (1) , 1-9
Abstract
Background: Cervical cancer is the fourth most common cancer in the world, affecting mainly women residing in low- and middle-income countries. Progression from a pre-invasive phase to that of an invasive phase generally takes years and provides a window of opportunity to screen for and treat precancerous lesions. Methods: This study is being conducted at four sites in north Karnataka, India. Community sensitization activities have been organized in the study areas to create awareness among stakeholders, including elected representatives, physicians, health care workers, and potential participants. Organized community based as well as hospital-based screening is being conducted using visual inspection with acetic acid (VIA). Screen positive women are referred to respective study hospitals for colposcopy and directed biopsy. Participants with confirmed high-grade cervical dysplasia (high-grade squamous intraepithelial lesions or HSIL) who fit all other eligibility criteria will be recruited to the study and will receive cryotherapy using CryoPop®, an innovative new cryotherapy device. Discussion: There is a need to develop an inexpensive, simple, and effective cryotherapy device for use by frontline health care providers at locations where screening and timely treatment can be given, accelerating access to cervical cancer prevention services and minimizing loss to follow-up of women with precancerous lesions who need treatment. Trial registration: Clinical Trial Registry - India CTRI/2019/01/017289 ClinicalTrials.Gov number NCT04154644. Registered on November 6, 2019.Keywords
All Related Versions
Funding Information
- National Cancer Institute (5UH3CA189923-05)
This publication has 9 references indexed in Scilit:
- Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysisThe Lancet Global Health, 2020
- Comparison of the depth of tissue necrosis between double-freeze and single-freeze nitrous oxide-based cryotherapyNigerian Medical Journal, 2016
- Prevalence of cervical dysplasia in western Uttar PradeshJournal of Cytology, 2013
- Moving cancer up the global health agendaThe Lancet, 2010
- Cervical cancer: the sub-Saharan African perspectiveReproductive Health Matters, 2008
- New technologies in cervical cytology screening: a word of cautionObstetrics & Gynecology, 1999
- Screening for Cervical CancerAnnals of Internal Medicine, 1990
- Effect of population screening for cancer of the uterine cervix in Nijmegen, The NetherlandsPreventive Medicine, 1986
- MORPHOMETRIC STUDY OF INTRA-EPITHELIAL NEOPLASIA OF THE UTERINE CERVIX1982